Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000316633 | SCV000342464 | uncertain significance | not provided | 2016-06-23 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000660520 | SCV000782621 | uncertain significance | Nemaline myopathy 2 | 2017-03-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000660520 | SCV003296785 | likely benign | Nemaline myopathy 2 | 2023-11-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000316633 | SCV005369400 | uncertain significance | not provided | 2023-07-21 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |